Biblio

Export 10 results:
Author Title Type [ Year(Desc)]
Filters: Author is DeCarli, Charles  [Clear All Filters]
2016
E. C. Camargo, Weinstein, G., Beiser, A. S., Tan, Z. S., DeCarli, C., Kelly-Hayes, M., Kase, C., Murabito, J. M., and Seshadri, S., “Association of Physical Function with Clinical and Subclinical Brain Disease: The Framingham Offspring Study.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1597-608, 2016.
I. Karakis, Pase, M. P., Beiser, A., Booth, S. L., Jacques, P. F., Rogers, G., DeCarli, C., Vasan, R. S., Wang, T. J., Himali, J. J., Annweiler, C., and Seshadri, S., “Association of Serum Vitamin D with the Risk of Incident Dementia and Subclinical Indices of Brain Aging: The Framingham Heart Study.”, J Alzheimers Dis, vol. 51, no. 2, pp. 451-61, 2016.
2018
M. L. Alosco, Sugarman, M. A., Besser, L. M., Tripodis, Y., Martin, B., Palmisano, J. N., Kowall, N. W., Au, R., Mez, J., DeCarli, C., Stein, T. D., McKee, A. C., Killiany, R. J., and Stern, R. A., “A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1347-1360, 2018.
2019
S. C. Conner, Benayoun, L., Himali, J. J., Adams, S. L., Yang, Q., DeCarli, C., Blusztajn, J. K., Beiser, A., Seshadri, S., and Delalle, I., “Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts.”, J Alzheimers Dis, vol. 68, no. 1, pp. 357-365, 2019.
C. DeCarli, Villeneuve, S., Maillard, P., Harvey, D., Singh, B., Carmichael, O., Fletcher, E., Olichney, J., Farias, S., Jagust, W., Reed, B., and Mungas, D., “Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury.”, J Alzheimers Dis, vol. 68, no. 1, pp. 187-196, 2019.
2020
H. Jang, Kim, H. Jin, Choe, Y. Sim, Kim, S. - J., Park, S., Kim, Y., Kim, K. Woon, Lyoo, C. Hyoung, Cho, H., Ryu, Y. Hoon, Choi, J. Yong, DeCarli, C., Na, D. L., and Seo, S. Won, “The Impact of Amyloid-β or Tau on Cognitive Change in the Presence of Severe Cerebrovascular Disease.”, J Alzheimers Dis, vol. 78, no. 2, pp. 573-585, 2020.
2021
C. B. Wright, DeRosa, J. T., Moon, M. P., Strobino, K., DeCarli, C., Cheung, Y. Kuen, Assuras, S., Levin, B., Stern, Y., Sun, X., Rundek, T., Elkind, M. S. V., and Sacco, R. L., “Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1129-1138, 2021.
2022
H. I. L. Jacobs, O'Donnell, A., Satizabal, C. L., Lois, C., Kojis, D., Hanseeuw, B. J., Thibault, E., Sanchez, J. S., Buckley, R. F., Yang, Q., DeCarli, C., Killiany, R., Sargurupremraj, M., Sperling, R. A., Johnson, K. A., Beiser, A. S., and Seshadri, S., “Associations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1603-1609, 2022.
K. Wittfeld, Raman, M. R., Conner, S. C., Aslam, A., Teumer, A., Nauck, M., Hosten, N., Habes, M., DeCarli, C., Vasan, R. S., Beiser, A. S., Himali, J. J., Seshadri, S., Grabe, H. J., and Satizabal, C. L., “Insulin-Like Growth Factor, Inflammation, and MRI Markers of Alzheimer's Disease in Predominantly Middle-Aged Adults.”, J Alzheimers Dis, vol. 88, no. 1, pp. 311-32, 2022.
2023
E. Z. Huie, Escudero, A., Saito, N., Harvey, D., Le Nguyen, M. -, Lucot, K. L., LaGrande, J., Mungas, D., DeCarli, C., Lamar, M., Schneider, J. A., Kapasi, A., Rissman, R. A., Teich, A. F., and Dugger, B. N., “TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1291-1301, 2023.